Cannabis for the treatment of amyotrophic lateral sclerosis: What is the patients’ view?Clémence Lacroix, Olivier Blin, Claude Desnuelle et al.|Revue Neurologique|2023Cited by 32
Serious Neurological Adverse Events of CeftriaxoneClémence Lacroix, Romain Guilhaumou, Joëlle Micallef et al.|Antibiotics|2021Cited by 29
What Do We Know About Medical Cannabis in Neurological Disorders and What Are the Next Steps?Clémence Lacroix, Olivier Blin, Isabelle Alleman-Brimault et al.|Frontiers in Pharmacology|2022Cited by 16
Cannabidiol and pharmacokinetics drug-drug interactions: Pharmacological toolboxClémence Lacroix, Olivier Blin, Romain Guilhaumou et al.|Therapies|2023Cited by 8
Antibiotic-induced neurological adverse drug reactionsClémence Lacroix, Joëlle Micallef, Olivier Blin et al.|Therapies|2023Cited by 6